Miyuki Yokoyama
Overview
Explore the profile of Miyuki Yokoyama including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
363
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Otaki Y, Watanabe T, Takahashi H, Sugai T, Yokoyama M, Tamura H, et al.
Circ Rep
. 2021 Mar;
1(4):187-195.
PMID: 33693136
Despite advances in endovascular therapy (EVT), peripheral artery disease (PAD) is a public health problem associated with high cardiovascular mortality. Iron deficiency (ID) is associated with poor clinical outcome in...
2.
Kinoshita D, Shishido T, Takahashi T, Yokoyama M, Sugai T, Watanabe K, et al.
Sci Rep
. 2020 Jun;
10(1):10345.
PMID: 32587339
Pulmonary arterial hypertension (PAH) is a progressive fatal disease caused by pulmonary arterial remodeling. Midkine regulates cell proliferation and migration, and it is induced by hypoxia, but its roles in...
3.
Toshima T, Watanabe T, Narumi T, Otaki Y, Shishido T, Aono T, et al.
Cardiovasc Res
. 2019 Aug;
116(5):983-994.
PMID: 31393559
Aims: Calcific aortic valve stenosis (CAVS) is the most common valvular heart disease and is increased with elderly population. However, effective drug therapy has not been established yet. This study...
4.
Sugai T, Watanabe T, Otaki Y, Goto J, Watanabe K, Toshima T, et al.
Circ J
. 2018 Oct;
82(12):3069-3075.
PMID: 30270315
Background: The prognosis of peripheral artery disease (PAD) and comorbid sarcopenia is poor. Some reports indicate that the computed tomography (CT) value of skeletal muscle, which reflects intramuscular fat deposition...
5.
Tani Y, Sato M, Yokoyama M, Yokoyama M, Takahashi T, Toyoda E, et al.
J Tissue Eng Regen Med
. 2018 Aug;
12(11):2179-2187.
PMID: 30075064
We have reported the usefulness of chondrocyte sheets on articular cartilage repair in animal experiments. Here, we investigated the regenerative effects of EP2 signalling with or without chondrocyte sheets. Forty-five...
6.
Takahashi T, Shishido T, Watanabe K, Sugai T, Toshima T, Kinoshita D, et al.
J Clin Hypertens (Greenwich)
. 2018 Jul;
20(9):1319-1326.
PMID: 30035383
Pulse pressure (PP) is a risk factor for cardiovascular diseases and is associated with increased afterload and myocardial oxygen demand. Brain natriuretic peptide (BNP) and heart-type fatty acid-binding protein (H-FABP)...
7.
Watanabe K, Shishido T, Otaki Y, Watanabe T, Sugai T, Toshima T, et al.
Heart Vessels
. 2018 Jun;
34(1):1-8.
PMID: 29936631
Increased reactive oxygen species (ROS) contributes to the development of endothelial dysfunction, which is involved in coronary artery spasm (CAS). Xanthine oxidoreductase (XOR) plays a pivotal role in producing both...
8.
Otaki Y, Watanabe T, Takahashi H, Sugai T, Yokoyama M, Nishiyama S, et al.
Circ J
. 2018 May;
82(7):1926-1934.
PMID: 29769460
Background: Peripheral artery disease (PAD) is a risk factor for the development of cardiovascular disease and death. Surfactant protein-D (SP-D) is a 43-kDa protein secreted from type II pneumocytes in...
9.
Takahashi T, Watanabe T, Shishido T, Watanabe K, Sugai T, Toshima T, et al.
Heart Vessels
. 2017 Dec;
33(7):733-739.
PMID: 29288403
Liver abnormalities have a strong impact on clinical outcomes in patients with heart failure (HF), and are known as cardio-hepatic syndrome. The non-alcoholic fatty liver disease (NAFLD) fibrosis score (NFS)...
10.
Yokoyama M, Watanabe T, Otaki Y, Watanabe K, Toshima T, Sugai T, et al.
Circ J
. 2017 Dec;
82(3):847-856.
PMID: 29187666
Background: Peripheral artery disease (PAD) is an athero-occlusive disease and a known risk factor for cardiovascular events. The controlling nutritional status (CONUT) score and geriatric nutritional risk index (GNRI) are...